Check our new article entitled “Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials” in Rheumatology (Oxford). 

Rheumatology key messages

  • The protection against renal flares conferred from belimumab is enhanced in the presence of antimalarials.
  • Antimalarials protect against renal flares, further supporting its use in all SLE patients unless contraindicated.
  • The prominent effect of low-dose belimumab warrants investigation of the efficacy of intermediate belimumab doses.

Parodis Lab

Karolinska University Hospital Solna 
SE-176 76 Stockholm